Zelira Therapeutics Ltd. announced that as part of a strategic consolidation of Zeliras operations, leadership will transfer to the United States based team. Dr. Richard Hopkins has decided to step-down as Chief Executive Officer and Managing Director ex-USA effective 15 May 2021. Dr. Hopkins will continue in his role while assisting and supporting the Company through the transition period.